MedPath

Topical Solution phenytoin effect on fluid after breast cancer surgery

Not Applicable
Conditions
breast cancer.
Malignant neoplasm of breast
Registration Number
IRCT201601111786N6
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
31
Inclusion Criteria

Inclusion: All patients with breast cancer undergoing modified radical mastectomy ; without a history of allergy to phenytoin ; without comorbodities
Exclusion criteria: patients who are not surgical; have a history of comorbidities; have a history of allergy to phenytoin

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DRAIN SECTRETION. Timepoint: first second and third day after surgery. Method of measurement: cc per 24 hours.;The number of days to drain. Timepoint: The day after surgery to drain down time. Method of measurement: day.;Seroma formation. Timepoint: 14 days after discharge. Method of measurement: clinical examination.
Secondary Outcome Measures
NameTimeMethod
Seroma formation. Timepoint: 14 days after discharge. Method of measurement: clinical examination.;The remaining drain time. Timepoint: The first day after surgery to drain down time. Method of measurement: day.
© Copyright 2025. All Rights Reserved by MedPath